Senior Oncology Consultant – Solid Tumor Sales (Remote)

Servier; Houston, Northern (TX, KY); Hybrid; USD 172,000 - 200,000; Full time

Benefits offered by this job

Medical insurance

Dental insurance

Vision insurance

401(k)

Unlimited sick time

Flexible time off

Job summary

Servier is seeking a Sr Oncology Consultant to drive sales in a remote Houston, TX territory, focusing on solid tumor indications such as LGG and CCA. The role requires a track record of top sales performance and experience launching new products.

Candidates should have a Bachelor’s degree (scientific preferred) and 5+ years in biotech/pharma sales, with oncology experience highly valued. Territory travel ~60% and strong cross-functional collaboration are expected.

Qualifications

• Bachelor’s Degree or equivalent; scientific background a plus.
• 5+ years in biotech/pharma, lab, or medical devices sales with strong results.
• Oncology/Solid Tumor sales experience preferred; track record of success.

Responsibilities

• Achieve sales targets for assigned territory in a remote footprint.
• Develop account and territory business plans to drive growth.
• Build long-term relationships with customers in all accounts.
• Present Servier brands professionally, ethically, and compliantly.
• Collaborate with commercial functions to meet customer needs.
• Monitor costs within territory budget guidance and comply with SOPs.

Skills

Oncology/Solid Tumor sales

Top sales performer

Product launch experience

Territory sales planning

Analytical mindset

Education

Bachelor’s Degree or equivalent

Scientific Degree a plus

Job description

Servier is seeking a Sr Oncology Consultant to drive sales in a remote Houston, TX territory, focusing on solid tumor indications such as LGG and CCA. The role requires a track record of top sales performance and experience launching new products.

Candidates should have a Bachelor’s degree (scientific preferred) and 5+ years in biotech/pharma sales, with oncology experience highly valued. Territory travel ~60% and strong cross-functional collaboration are expected.